Laurent Alric

5PUBLICATIONS
19CO-AUTHORS
Nutritional epidemiologyCardiology (incl. cardiovascular diseases)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 18, 2026
High thrombin activity associated with crohn's disease induces microbiota pathogenicity contributing to mucosal inflammation.

|Jan 22, 2026
Impact of ANCA specificity on risk of cardiovascular events and death in ANCA-associated vasculitis.

Jon Idoate Lacasia, Morgane Mourguet, Thomas Villeneuve

|Mar 05, 2025
Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren's disease: Prepcov multicentre trial.

Laurent Alric, Clara Brusq, Marion Migueres

|Sep 20, 2017
Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial.

David Wyles, Fred Poordad, Stanley Wang

|Sep 09, 2016
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.

Luca Arcaini, Caroline Besson, Marco Frigeni

Pageof 1

Frequent Collaborators

1 joint publications

Luca Arcaini

1 joint publications

Caroline Besson

1 joint publications

Marco Frigeni

1 joint publications

Hélène Fontaine